We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

New Rapid Lateral Flow Antigen COVID-19 Testing Platform Processes 200-300 People Each Hour and Reports Results in 15 Minutes

By HospiMedica International staff writers
Posted on 20 Oct 2020
Print article
Illustration
Illustration
A new rapid lateral flow antigen COVID-19 testing platform gives testers the ability to process an unprecedented 200-300 people each hour and report results within 15 minutes utilizing testing kits from Quidel, BD and Abbott.

The COVID CleanPass system from Apollo Medco (Atlanta, GA, USA) is a mobile app-linked, HIPAA compliant, cloud secure and data-backed COVID-19 testing platform. Straight forward and effortless to operate, its built-in software walks anyone through all and every step of testing. Its trouble-free transportability and total weight of less than 20 pounds makes any location perfect for use. Its bulletproof and waterproof case floats and protects all electronics inside, no matter how harsh the environment. In case of power failure, its eight-hour battery or solar powered panels ensure that testing continues.

Hassle-free, simple to operate, and compatible with worldwide power sources, the COVID CleanPass is a reliable system that is enabling businesses across the globe to reopen and start growing with absolute peace of mind. With its compact form and overhead airline compliance, immediate global deployment to the next viral outbreak is actually possible. Currently, Apollo Medco is beta testing its COVID-19 testing platform and applying for Emergency Use Authorization from the US Food and Drug Administration which is expected in November 2020. Distribution of the new COVID CleanPass system is then expected to begin in late November 2020.

"Our new COVID CleanPass platform is the most advanced, quality-assured, rapid testing platform in the world," said Apollo Medco President & CEO Ken Dunwody. "We've supercharged the overall COVID testing process by delivering fast and accurate results to the patient in an efficient manner. The front-end of our platform includes our Apollo 'Mission Control' diagnostic unit while the back-end of our platform includes our mobile app-linked, cloud secure, HIPAA compliant test reporting system which includes a dynamic Web portal that maps, tracks and reports COVID hot zones in real time."

"Each Apollo Medco testing system is contained in a portable rugged case and includes a battery that lasts 10 hours, iPad with the proprietary mobile app system, time tracking system, printer and a universal lateral flow analysis device. All testing companies will have access to our HIPPA compliant Web portal for accepting new testing requests, scheduling, assigning systems to testers and managing testing assignments. Automatic reporting of all COVID-19 tests through the Apollo Medco COVID CleanPass system will enable testing companies to provide quick, accurate information," added Dunwody.

Related Links:
Apollo Medco

Gold Member
12-Channel ECG
CM1200B
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bronchoscopy Head Support
Reison 10-330

Print article

Channels

Critical Care

view channel
Image: A demonstration of the on-skin wearable bioelectronic device (Photo courtesy of University of Missouri)

On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants

A team of researchers at the University of Missouri (Columbia, MO, USA) has achieved a milestone in developing a state-of-the-art on-skin wearable bioelectronic device. This development comes from a lab... Read more

Surgical Techniques

view channel
Image: The hyperspectral imaging system extracts molecular vibrations of different resins and distinguishes between them with high reproducibility (Photo courtesy of Hiroshi Takemura from Tokyo University of Science)

Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery

Hyperspectral imaging (HSI) is an advanced technique that captures and processes information across a given electromagnetic spectrum. Near-infrared hyperspectral imaging (NIR-HSI) has particularly gained... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more